EN PL
CASE REPORT
Diagnostic problems based on observations of a female patient suffering from myasthenia gravis coexisting with lupus-like syndrome and diagnosed borreliosis
 
More details
Hide details
 
Online publication date: 2010-11-16
 
 
Reumatologia 2010;48(5):349-352
 
KEYWORDS
ABSTRACT
Coexistence of one or more autoimmune diseases seems not to be so rare. Systemic lupus erythematosus (SLE) is the disease most often coexisting with other autoimmune disorders. Myasthenia gravis less often coexists with SLE, but there have already appeared descriptions of such occasional cases. The case of a female patient with diagnosed myasthenia gravis followed by thymectomy and with lupus-like syndrome diagnosed several years later is presented in this study. Addition of Borrelia burgdorferi infection complicated the clinical picture. Diagnostic difficulties encountered in the observed case are presented in this study.
REFERENCES (19)
1.
Mackay IR. Clustering and commonalities among autoimmune diseases. J Autoimmunity 2009; 33: 170-177.   .
 
2.
McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in population of patients with lupus erythematosus. Ann Rheum Dis 2000; 59: 230-232.   .
 
3.
Poulas K, Tsibri E, Kokla A, et al. Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psych 2001; 71: 352-356.   .
 
4.
Phillips LH, Torner JC, Anderson MS, et al. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992; 42: 1883-1893.   .
 
5.
Alshekhlee A., Miles JD, Katirji B. et al. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009; 72: 1548-1554.   .
 
6.
Gedliczka O, Dróżdż W, Otto T, Hausmanowa-Petrusewicz I. Wpływ usunięcia grasicy na przebieg myasthenia gravis. Pol Przegl Chir 1994; 66: 317-328.   .
 
7.
Hrycek A. A sequence of pathologic events in a patient after thymectomy for myasthenia gravis. Rheumatol Int, dostępny online.   .
 
8.
Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009; 11: 229.   .
 
9.
Wolf SM, Barrows H. Myasthenia gravis and systemic lupus erythematosus. Arch Neurol 1966; 14: 254-258. .
 
10.
Boonen A, Rennenberg R, van der Linden S. Thymoma associated systemic lupus erythematosus, exacerbation after thymectomy. A case reports and review of the literature. Rheumatology 2000; 3: 1044-1046. .
 
11.
Louzir B, Ben Abdelhafidh N, Bahri M. Association of systemic lupus erythematosus and myastenia gravis. A new case report. Tunis Med 2003; 81, 953-966. .
 
12.
Park MJ, Kim JA, Lee SS, et al. Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports. J Korean Med Sci 2004; 19: 134-136. .
 
13.
Hrycek A. Systemic lupus erythematosus and myasthenia gravis. Pol Arch Med Wewn 2009; 119: 582-585. .
 
14.
Hrycek A. The role of prolactin in immunological processes. Wiad Lek 1998; 51: 226-233. .
 
15.
Tsizerling N, Pirskanen R, Matel G et al. Raised prolactin levels in myasthenia gravis: two case reports an a study of two patient populations. Acta Neurol Scand 2006; 14: 346-349. .
 
16.
Yang M, Huang L, Liu et al. Prolactin may be a promising therapeutic target for myasthenia gravis: hypothesis and importance. Med Hypothesis 2008; 70: 1017-1020. .
 
17.
Orbach H, Zandman-Goddard G. Amital H, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 2007; 1109: 385-400. .
 
18.
Hrycek A, Cieślik P, Tustanowski J, et al. Selected serum cytokines In systemic erythmatosus treated with quinqgolide. Lupus 2001; 10: 424-440. .
 
19.
Hrycek A. Borelioza – „wielki imitator” trudności w diagnostyce i różnicowaniu choroby. Wiad Lek 2001; 54: 64-72.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top